These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23951517)

  • 41. Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients.
    Göbel A; Kuhlmann JD; Link T; Wimberger P; Browne AJ; Rauner M; Hofbauer LC; Rachner TD
    Breast Cancer Res Treat; 2017 Aug; 164(3):737-743. PubMed ID: 28526959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Influence of specific osteoporosis drugs on fracture healing].
    Hesse E; Neuerburg C; Kammerlander C; Stumpf U; Stange R; Böcker W
    Unfallchirurg; 2019 Jul; 122(7):506-511. PubMed ID: 31123799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Serum Sclerostin Levels in Patients With Active Acromegaly.
    Pekkolay Z; Kılınç F; Gozel N; Önalan E; Tuzcu AK
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31821453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of osteoporotic fracture healing by vibration treatment: The role of osteocytes.
    Cheung WH; Wong RMY; Choy VMH; Li MCM; Cheng KYK; Chow SKH
    Injury; 2021 Jun; 52 Suppl 2():S97-S100. PubMed ID: 32654846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of sclerostin scFv and the effect of sclerostin scFv on healing of osteoporotic femur fracture in rats.
    Yao Q; Ni J; Hou Y; Ding L; Zhang L; Jiang H
    Cell Biochem Biophys; 2014 Jun; 69(2):229-35. PubMed ID: 24254971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-osteoporosis therapy and fracture healing.
    Larsson S; Fazzalari NL
    Arch Orthop Trauma Surg; 2014 Feb; 134(2):291-7. PubMed ID: 22684739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental agents to improve fracture healing: utilizing the WNT signaling pathway.
    Haffner-Luntzer M
    Injury; 2021 Jun; 52 Suppl 2():S44-S48. PubMed ID: 33234263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sclerostin antibody treatment enhances metaphyseal bone healing in rats.
    Agholme F; Li X; Isaksson H; Ke HZ; Aspenberg P
    J Bone Miner Res; 2010 Nov; 25(11):2412-8. PubMed ID: 20499342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.
    Ominsky MS; Vlasseros F; Jolette J; Smith SY; Stouch B; Doellgast G; Gong J; Gao Y; Cao J; Graham K; Tipton B; Cai J; Deshpande R; Zhou L; Hale MD; Lightwood DJ; Henry AJ; Popplewell AG; Moore AR; Robinson MK; Lacey DL; Simonet WS; Paszty C
    J Bone Miner Res; 2010 May; 25(5):948-59. PubMed ID: 20200929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained-release of sclerostin single-chain antibody fragments using poly(lactic-co-glycolic acid) microspheres for osteoporotic fracture repair.
    Li M; Li S; Liu J; Cui X; Zhang S; Zhou J; Wang X; Yao Q
    J Biomed Mater Res A; 2019 Aug; 107(8):1832-1840. PubMed ID: 31012249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between serum sclerostin level and bone density status in children on regular hemodialysis.
    Elsalam MA; El-Abden MZ; Mahmoud E; Zahab ZA; Ahmed H
    Saudi J Kidney Dis Transpl; 2019; 30(5):1022-1031. PubMed ID: 31696839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper.
    Goldhahn J; Féron JM; Kanis J; Papapoulos S; Reginster JY; Rizzoli R; Dere W; Mitlak B; Tsouderos Y; Boonen S
    Calcif Tissue Int; 2012 May; 90(5):343-53. PubMed ID: 22451221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.
    Rauner M; Taipaleenmäki H; Tsourdi E; Winter EM
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases.
    Fabre S; Funck-Brentano T; Cohen-Solal M
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats.
    Agholme F; Isaksson H; Li X; Ke HZ; Aspenberg P
    Acta Orthop; 2011 Oct; 82(5):628-32. PubMed ID: 22103277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunolocalization of osteocyte-derived molecules during bone fracture healing of mouse ribs.
    Liu Z; Yamamoto T; Hasegawa T; Hongo H; Tsuboi K; Tsuchiya E; Haraguchi M; Abe M; Freitas PH; Kudo A; Oda K; Li M; Amizuka N
    Biomed Res; 2016; 37(2):141-51. PubMed ID: 27108883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations of serum sclerostin with bone mineral density, markers of bone metabolism and thalassaemia characteristics in adult patients with transfusion-dependent beta-thalassaemia.
    Sapunarova K; Goranova-Marinova V; Georgiev P; Deneva T; Tsvetkova S; Grudeva-Popova Z
    Ann Med; 2020; 52(3-4):94-108. PubMed ID: 32212941
    [No Abstract]   [Full Text] [Related]  

  • 58. Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis.
    Wakolbinger R; Muschitz C; Wallwitz J; Bodlaj G; Feichtinger X; Schanda JE; Resch H; Baierl A; Pietschmann P
    Wien Klin Wochenschr; 2020 Jan; 132(1-2):19-26. PubMed ID: 31912287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.
    Turk JR; Deaton AM; Yin J; Stolina M; Felx M; Boyd G; Bienvenu JG; Varela A; Guillot M; Holdsworth G; Wolfreys A; Dwyer D; Kumar SV; de Koning EM; Qu Y; Engwall M; Locher K; Ward LD; Glaus C; He YD; Boyce RW
    Regul Toxicol Pharmacol; 2020 Aug; 115():104697. PubMed ID: 32590049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sclerostin and skeletal health.
    Sharifi M; Ereifej L; Lewiecki EM
    Rev Endocr Metab Disord; 2015 Jun; 16(2):149-56. PubMed ID: 25669441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.